The Latest: Pfizer aims for full FDA approval of vaccine
NEW YORK - Drugmaker Pfizer has begun the process to earn full U.S. regulatory approval for its COVID-19 vaccine for people aged 16 and older. |!| Pawtucket
NEW YORK - Drugmaker Pfizer has begun the process to earn full U.S. regulatory approval for its COVID-19 vaccine for people aged 16 and older. |!| Pawtucket